Cargando…
Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin
OBJECTIVE: To add to the evidence on comparative long-term effects of insulin analog glargine versus human NPH insulin on the risk for cancer. RESEARCH DESIGN AND METHODS: We identified cohorts of initiators of glargine and human NPH without an insulin prescription during the prior 19 months among p...
Autores principales: | Stürmer, Til, Marquis, M. Alison, Zhou, Haibo, Meigs, James B., Lim, Soo, Blonde, Lawrence, MacDonald, Eileen, Wang, Ray, LaVange, Lisa M., Pate, Virginia, Buse, John B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816915/ https://www.ncbi.nlm.nih.gov/pubmed/23877991 http://dx.doi.org/10.2337/dc13-0263 |
Ejemplares similares
-
Electronic Medical Record Cancer Incidence over Six Years Comparing New Users of Glargine with New Users of NPH Insulin
por: Lim, Soo, et al.
Publicado: (2014) -
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
por: Sharplin, Peter, et al.
Publicado: (2009) -
Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus
NPH Insulin during Pregnancy
por: Lepercq, Jacques, et al.
Publicado: (2012) -
Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review
por: Hagenmeyer, Ernst-Günther, et al.
Publicado: (2011) -
Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain
por: Delgado, E
Publicado: (2012)